946 related articles for article (PubMed ID: 17458771)
1. Respiratory syncytial virus infection in adults.
Falsey AR
Semin Respir Crit Care Med; 2007 Apr; 28(2):171-81. PubMed ID: 17458771
[TBL] [Abstract][Full Text] [Related]
2. Respiratory syncytial virus infection in elderly and high-risk adults.
Falsey AR; Hennessey PA; Formica MA; Cox C; Walsh EE
N Engl J Med; 2005 Apr; 352(17):1749-59. PubMed ID: 15858184
[TBL] [Abstract][Full Text] [Related]
3. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host.
Wendt CH; Hertz MI
Semin Respir Infect; 1995 Dec; 10(4):224-31. PubMed ID: 8668850
[TBL] [Abstract][Full Text] [Related]
4. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with respiratory syncytial virus vaccines.
Piedra PA
Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S94-9. PubMed ID: 12671459
[TBL] [Abstract][Full Text] [Related]
6. Respiratory syncytial virus infections: characteristics and treatment.
Chidgey SM; Broadley KJ
J Pharm Pharmacol; 2005 Nov; 57(11):1371-81. PubMed ID: 16259768
[TBL] [Abstract][Full Text] [Related]
7. Respiratory syncytial virus infection in adults.
Murata Y; Falsey AR
Antivir Ther; 2007; 12(4 Pt B):659-70. PubMed ID: 17944273
[TBL] [Abstract][Full Text] [Related]
8. Respiratory syncytial virus persistence in chronic obstructive pulmonary disease.
Sikkel MB; Quint JK; Mallia P; Wedzicha JA; Johnston SL
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S63-70. PubMed ID: 18820581
[TBL] [Abstract][Full Text] [Related]
9. [Respiratory syncytial virus: as an etiological agent of respiratory tract infection in children and adults].
Belino-Studzińska P; Pancer K
Przegl Epidemiol; 2008; 62(4):767-75. PubMed ID: 19209739
[TBL] [Abstract][Full Text] [Related]
10. Young infants can develop protective levels of neutralizing antibody after infection with respiratory syncytial virus.
Shinoff JJ; O'Brien KL; Thumar B; Shaw JB; Reid R; Hua W; Santosham M; Karron RA
J Infect Dis; 2008 Oct; 198(7):1007-15. PubMed ID: 18702606
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.
Whimbey E; Champlin RE; Englund JA; Mirza NQ; Piedra PA; Goodrich JM; Przepiorka D; Luna MA; Morice RC; Neumann JL
Bone Marrow Transplant; 1995 Sep; 16(3):393-9. PubMed ID: 8535312
[TBL] [Abstract][Full Text] [Related]
12. Respiratory tract infections caused by respiratory syncytial virus in children. Diagnosis and treatment.
Van Woensel JB; Kimpen JL; Brand PL
Minerva Pediatr; 2001 Apr; 53(2):99-106. PubMed ID: 11404731
[TBL] [Abstract][Full Text] [Related]
13. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
[TBL] [Abstract][Full Text] [Related]
14. Respiratory syncytial virus: A continuing culprit and conundrum.
Hall CB
J Pediatr; 1999 Aug; 135(2 Pt 2):2-7. PubMed ID: 10431132
[TBL] [Abstract][Full Text] [Related]
15. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience.
DeVincenzo JP; Hirsch RL; Fuentes RJ; Top FH
Bone Marrow Transplant; 2000 Jan; 25(2):161-5. PubMed ID: 10673674
[TBL] [Abstract][Full Text] [Related]
16. Respiratory syncytial virus infection in recipients of allogeneic stem-cell transplantation: a retrospective study of the incidence, clinical features, and outcome.
Avetisyan G; Mattsson J; Sparrelid E; Ljungman P
Transplantation; 2009 Nov; 88(10):1222-6. PubMed ID: 19935377
[TBL] [Abstract][Full Text] [Related]
17. Moderate local and systemic respiratory syncytial virus-specific T-cell responses upon mild or subclinical RSV infection.
de Waal L; Koopman LP; van Benten IJ; Brandenburg AH; Mulder PG; de Swart RL; Fokkens WJ; Neijens HJ; Osterhaus AD
J Med Virol; 2003 Jun; 70(2):309-18. PubMed ID: 12696123
[TBL] [Abstract][Full Text] [Related]
18. Age-related differences in pulmonary cytokine response to respiratory syncytial virus infection: modulation by anti-inflammatory and antiviral treatment.
Boukhvalova MS; Yim KC; Kuhn KH; Hemming JP; Prince GA; Porter DD; Blanco JC
J Infect Dis; 2007 Feb; 195(4):511-8. PubMed ID: 17230410
[TBL] [Abstract][Full Text] [Related]
19. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
Liu V; Dhillon GS; Weill D
Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
[TBL] [Abstract][Full Text] [Related]
20. Human metapneumovirus infection in young children hospitalized with acute respiratory tract disease: virologic and clinical features.
Caracciolo S; Minini C; Colombrita D; Rossi D; Miglietti N; Vettore E; Caruso A; Fiorentini S
Pediatr Infect Dis J; 2008 May; 27(5):406-12. PubMed ID: 18382388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]